Tracking mesenchymal stem cell tumor-homing using fluorescent silica nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cell Biology

Background:

• Stem cell tracking is crucial for understanding stem-cell-based therapies, particularly for human mesenchymal stem cells (hMSCs) in cancer treatment.
• Nanoparticle contrast agents offer advanced imaging but face challenges in development, retention, and safety, limiting accessibility.
• Core-shell fluorescent silica nanoparticles (C dots) are commercially available and FDA-approved, presenting a potential solution.

Purpose of the Study:

• To evaluate the suitability of C dots as a contrast agent for tracking hMSCs in cancer therapy.
• To assess the cellular retention, inter-cellular transfer, and impact of C dots on hMSC properties.

Main Methods:

• Investigated the application of 500 nm core-shell fluorescent silica nanoparticles (C dots).
• Assessed cellular retention and transfer using a co-culture Boyden chamber system.
• Evaluated the influence of C dots on hMSC viability, proliferation, differentiation, and tumor tropism.

Main Results:

• Demonstrated prolonged cellular retention of C dots by hMSCs for up to one month.
• Observed minimal contrast agent transfer between cells for at least three weeks.
• Showed minimal influence of C dots on hMSC viability, proliferation, differentiation, and tumor tropism.

Conclusions:

• Core-shell fluorescent silica nanoparticles (C dots) are a viable and promising contrast agent for tracking hMSCs.
• These nanoparticles exhibit favorable retention and minimal transfer characteristics, crucial for in vivo applications.
• C dots do not adversely affect critical hMSC functions, supporting their use in stem cell therapy research and clinical trials.